Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
349
Appointments
169
Departures
38
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,771 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | H&R BLOCK INC | Matthew E. Winter | director of the Companydirector of the Company | Departed | n/a | SEC 8-K |
| Aug 14, 2026 | JACOBS SOLUTIONS INC. | Shannon Miller | President, Strategy, Growth & DigitalPresident | Departed | Aug 10, 2026 | SEC 8-K |
| Aug 14, 2026 | LABCORP HOLDINGS INC. | Megan D. Bailey | Executive Vice President and President, Central Laboratories and InternationalPresident | Departed | Sep 4, 2026 | SEC 8-K |
| Aug 14, 2026 | LABCORP HOLDINGS INC. | Brian J. Caveney, M.D. | Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific OfficerPresident | Role change | Sep 1, 2026 | SEC 8-K |
| Aug 14, 2026 | Lifeward Ltd. | Robert J. Marshall, Jr. | DirectorDirector | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 14, 2026 | Lifeward Ltd. | Michael Swinford | DirectorDirector | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 14, 2026 | Lifeward Ltd. | William Mark Sigsbee | DirectorDirector | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 14, 2026 | Lifeward Ltd. | Almog Adar | Chief Financial OfficerCFO | Departed | Sep 30, 2026 | SEC 8-K |
| Aug 14, 2026 | Longevity Health Holdings, Inc. | Scott Frisch | Board of DirectorsBoard of Directors | Departed | Aug 11, 2026 | SEC 8-K |
| Aug 14, 2026 | Neumora Therapeutics, Inc. | Paul L. Berns | Executive Chairperson of the Board of DirectorsExecutive Chairperson of the Board of Directors | Role change | Aug 14, 2026 | SEC 8-K |
| Aug 14, 2026 | Neumora Therapeutics, Inc. | Joshua Pinto, Ph.D. | Chief Executive OfficerCEO | Appointed | Aug 14, 2026 | SEC 8-K |
| Aug 14, 2026 | NewAmsterdam Pharma Co N.V. | Robert W. Gunning | principal accounting officerprincipal accounting officer | Appointed | Aug 10, 2026 | SEC 8-K |
| Aug 14, 2026 | NewAmsterdam Pharma Co N.V. | Louise Kooij | principal accounting officerprincipal accounting officer | Departed | n/a | SEC 8-K |
| Aug 14, 2026 | NightFood Holdings, Inc. | Lei Sonny Wang | member of the Board of Directorsmember of the Board of Directors | Departed | Aug 7, 2026 | SEC 8-K |
| Aug 14, 2026 | NightFood Holdings, Inc. | Thomas Morse | member of the Boardmember of the Board | Departed | Aug 7, 2026 | SEC 8-K |
| Aug 14, 2026 | NightFood Holdings, Inc. | Darren Kenney | member of the Boardmember of the Board | Appointed | Aug 7, 2026 | SEC 8-K |
| Aug 14, 2026 | NightFood Holdings, Inc. | Ronald J. Stauber | member of the Boardmember of the Board | Appointed | Aug 7, 2026 | SEC 8-K |
| Aug 14, 2026 | NightFood Holdings, Inc. | Yury Pyatigorsky | Chief Financial OfficerCFO | Appointed | Aug 10, 2026 | SEC 8-K |
| Aug 14, 2026 | NightFood Holdings, Inc. | Jimmy Chan | Chief Financial OfficerCFO | Departed | n/a | SEC 8-K |
| Aug 14, 2026 | Oportun Financial Corp | Scott Scheirman | Class I directorClass I director | Appointed | Aug 11, 2026 | SEC 8-K |
- H&R BLOCK INCDeparted
Matthew E. Winter director of the Company
Filed Aug 14, 2026SEC 8-K
- JACOBS SOLUTIONS INC.Departed
Shannon Miller President
Filed Aug 14, 2026Effective Aug 10, 2026SEC 8-K
- LABCORP HOLDINGS INC.Departed
Megan D. Bailey President
Filed Aug 14, 2026Effective Sep 4, 2026SEC 8-K
- LABCORP HOLDINGS INC.Role change
Brian J. Caveney, M.D. President
Filed Aug 14, 2026Effective Sep 1, 2026SEC 8-K
- Lifeward Ltd.Departed
Robert J. Marshall, Jr. Director
Filed Aug 14, 2026Effective Aug 13, 2026SEC 8-K
- Lifeward Ltd.Departed
Michael Swinford Director
Filed Aug 14, 2026Effective Aug 13, 2026SEC 8-K
- Lifeward Ltd.Departed
William Mark Sigsbee Director
Filed Aug 14, 2026Effective Aug 13, 2026SEC 8-K
- Lifeward Ltd.Departed
Almog Adar CFO
Filed Aug 14, 2026Effective Sep 30, 2026SEC 8-K
- Longevity Health Holdings, Inc.Departed
Scott Frisch Board of Directors
Filed Aug 14, 2026Effective Aug 11, 2026SEC 8-K
- Neumora Therapeutics, Inc.Role change
Paul L. Berns Executive Chairperson of the Board of Directors
Filed Aug 14, 2026Effective Aug 14, 2026SEC 8-K
- Neumora Therapeutics, Inc.Appointed
Joshua Pinto, Ph.D. CEO
Filed Aug 14, 2026Effective Aug 14, 2026SEC 8-K
- NewAmsterdam Pharma Co N.V.Appointed
Robert W. Gunning principal accounting officer
Filed Aug 14, 2026Effective Aug 10, 2026SEC 8-K
- NewAmsterdam Pharma Co N.V.Departed
Louise Kooij principal accounting officer
Filed Aug 14, 2026SEC 8-K
- NightFood Holdings, Inc.Departed
Lei Sonny Wang member of the Board of Directors
Filed Aug 14, 2026Effective Aug 7, 2026SEC 8-K
- NightFood Holdings, Inc.Departed
Thomas Morse member of the Board
Filed Aug 14, 2026Effective Aug 7, 2026SEC 8-K
- NightFood Holdings, Inc.Appointed
Darren Kenney member of the Board
Filed Aug 14, 2026Effective Aug 7, 2026SEC 8-K
- NightFood Holdings, Inc.Appointed
Ronald J. Stauber member of the Board
Filed Aug 14, 2026Effective Aug 7, 2026SEC 8-K
- NightFood Holdings, Inc.Appointed
Yury Pyatigorsky CFO
Filed Aug 14, 2026Effective Aug 10, 2026SEC 8-K
- NightFood Holdings, Inc.Departed
Jimmy Chan CFO
Filed Aug 14, 2026SEC 8-K
- Oportun Financial CorpAppointed
Scott Scheirman Class I director
Filed Aug 14, 2026Effective Aug 11, 2026SEC 8-K